The short version of research chemical fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-09-15 and is reviewed periodically as new material appears.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
Pralidoxime is not effective in reactivating acetylcholinesterase inhibited by some older nerve agents such as soman or the Novichok nerve agents, described in the literature as being up to eight times more toxic than the nerve agent VX. The US Army has funded studies of the use of galantamine along with atropine in the treatment of a number of nerve agents, including soman and the Novichok agents. An unexpected synergistic interaction was seen to occur between galantamine (given between five hours before to thirty minutes after exposure) and atropine in an amount of 6 mg/kg or higher. Increasing the dose of galantamine from 5 to 8 mg/kg decreased the dose of atropine needed to protect experimental animals from the toxicity of soman in dosages 1.5 times the LD50 (lethal dose in half the animals studied). There have been differing claims about the persistence of Novichok and binary precursors in the environment. One view is that it is not affected by normal weather conditions, and may not decompose as quickly as other organophosphates. However, Mirzayanov states that Novichok decomposes within four months.
== Early life and education == Francisco "Kiko" Tiu Laurel Jr. was born to Francisco Sr. and Bella Tiu Laurel. As a teenager, Laurel was involved in the Frabelle Fishing Company, and became a full-time employee at 20, where he started in the Engineering department before moving into sales and leadership. He did not finish a college degree, saying that he had dropped out at the age of 19 to find a job that would support his first child.
=== 9/11 response === Following the September 11, 2001, terrorist attacks, President George W. Bush issued Executive Order 13224 under the IEEPA to block the assets of terrorist organizations. The president delegated blocking authority to federal agencies led by the U.S. Treasury. In October 2001, Congress passed the USA PATRIOT Act which, in part, enhanced IEEPA asset blocking provisions under §1702(a)(1)(B) to permit the blocking of assets during the "pendency of an investigation." This statutory change gave the Treasury's Office of Foreign Assets Control the power to block assets without the need to provide evidence of the blocking subject's wrongdoing nor to permit the blocking subject a chance to effectively respond to the allegations in court. Executing these blocking actions led to a series of legal cases challenging federal authority to indefinitely prevent charitable organizations from accessing their assets held in the United States.
A Komodo dragon may attempt to speed up the process by ramming the carcass against a tree to force it down its throat, sometimes ramming so forcefully that the tree is knocked down. A small tube under the tongue that connects to the lungs allows it to breathe while swallowing. After eating up to 80% of its body mass in one meal, it drags itself to a sunny location to speed digestion, as the food could rot and poison the dragon if left undigested in its stomach for too long. Because of their slow metabolism, large dragons can survive on as few as 12 meals a year. After digestion, the Komodo dragon regurgitates a mass of horns, hair, and teeth known as the gastric pellet, which is covered in malodorous mucus. After regurgitating the gastric pellet, it rubs its face in the dirt or on bushes to get rid of the mucus.
Sources: en.wikipedia.org
===== SeV suppression of regulatory T cells ===== Experiments with animal models have shown that, even after UV inactivation, SeV can block T-cell-mediated regulatory immunosuppression in tumors. The blocking mechanism is associated with the stimulation of SeV inactivated virions of interleukin 6 (IL-6) secretion by mature DCs. These effects lead to the eradication of most model tumors and inhibit the growth of the rest. It has been shown that F protein alone can trigger IL-6 production in DC in a fusion-independent manner.
== Treatment == The goals of treatment in IPF are essentially to reduce the symptoms, stop disease progression, prevent acute exacerbations, and prolong survival. Preventive care (e.g. vaccinations) and symptom-based treatment should be started early in every patient.
The three substrates of this enzyme are L-aspartic acid, water, and oxidised nicotinamide adenine dinucleotide (NAD+}. Its products are oxaloacetic acid, ammonia, reduced NADH, and a proton. Nicotinamide adenine dinucleotide phosphate can be used as an alternative cofactor. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-NH2 group of donors with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is L-aspartate:NAD(P)+ oxidoreductase (deaminating). Other names in common use include NAD-dependent aspartate dehydrogenase, NADH2-dependent aspartate dehydrogenase, and NADP+-dependent aspartate dehydrogenase. This enzyme participates in nicotinate and nicotinamide metabolism.
In 1940–1941, some 325,000 Polish citizens were deported by the Soviet Union. The number of Polish citizens who died at the hands of the Soviets is estimated at less than 100,000. In 1943–1944, Ukrainian nationalists associated with the Organization of Ukrainian Nationalists (OUN) and the Ukrainian Insurgent Army perpetrated the Massacres of Poles in Volhynia and Eastern Galicia. Estimates of the number of Polish civilian victims vary greatly, from tens to hundreds of thousands. Approximately 90% of Poland's war casualties were the victims of prisons, death camps, raids, executions, the annihilation of ghettos, epidemics, starvation, excessive work and ill treatment. The war left one million children orphaned and 590,000 persons disabled. The country lost 38% of its national assets (whereas Britain lost only 0.8%, and France only 1.5%). Nearly half of pre-war Poland was expropriated by the Soviet Union, including the two great cultural centers of Lwów and Wilno. The policies of Nazi Germany have been judged after the war by the International Military Tribunal at the Nuremberg trials and Polish genocide trials to be aimed at extermination of Jews, Poles and Roma, and to have "all the characteristics of genocide in the biological meaning of this term".
On March 14, 2016, a National Labor Relations Board (NLRB) administrative law judge concluded that Chipotle's social media policy, and more specifically its application towards an employee who posted tweets regarding wages and working conditions, violated the National Labor Relations Act (NLRA). A former Chipotle employee in Havertown, Pennsylvania, wrote a series of tweets from his personal account about hourly workers being required to work on snow days. Chipotle instructed the employee to delete the tweets. The NLRB judge determined that Chipotle's request to delete the tweets violated the NLRA even though the employee was not disciplined as a result of his tweets. In July 2021, Chipotle rolled out limited edition gold foil at participating locations to celebrate American athletes competing in Tokyo at the 2020 Summer Olympics. On October 28, 2021, Chipotle announced $1 million of burritos to be given away for free for the first 30,000 people to play the Chipotle experience on the video game Roblox. The site ended up experiencing a three-day outage, but the company clarified that it was not the fault of Chipotle. On February 16, 2023, MoneyGram Haas F1 Team announced a sponsorship deal with Chipotle. The Chipotle logo will be featured on both the nose and side of the VF-23, race-suits of drivers Kevin Magnussen and Nico Hulkenberg and team apparel.
Sources: en.wikipedia.org
When submerged, the water pressure on a submarine's hull can reach 4 MPa (580 psi) for steel submarines and up to 10 MPa (1,500 psi) for titanium submarines like K-278 Komsomolets, while interior pressure remains relatively unchanged. This difference results in hull compression, which decreases displacement. Water density also marginally increases with depth, as the salinity and pressure are higher. This change in density incompletely compensates for hull compression, so buoyancy decreases as depth increases. A submerged submarine is in an unstable equilibrium, having a tendency to either sink or float to the surface. Keeping a constant depth requires continual operation of either the depth control tanks or control surfaces. Submarines in a neutral buoyancy condition are not intrinsically trim-stable. To maintain desired longitudinal trim, submarines use forward and aft trim tanks. Pumps move water between the tanks, changing weight distribution and pitching the sub up or down. A similar system may be used to maintain transverse trim.
2 PaI5 → 2 Pa + 5 I2 In 1961, the United Kingdom Atomic Energy Authority (UKAEA) produced 127 grams of 99.9% pure protactinium-231 by processing 60 tonnes of waste material in a 12-stage process, at a cost of about US$500,000. For many years, this was the world's only significant supply of protactinium, which was provided to various laboratories for scientific studies. The Oak Ridge National Laboratory in the US provided protactinium at a cost of about US$280/gram.
Natriuretic peptide precursor C, also known as NPPC, is a protein that in humans is encoded by the NPPC gene. The precursor NPPC protein is cleaved to the 22 amino acid peptide C-type natriuretic peptide (CNP).
In Virus (2019), directed by Aashiq Abu, Kallingal played nurse Akhila, a character based on Lini Puthussery — the nurse who died treating Kerala's first patient in the 2018 Nipah virus outbreak. Lini Puthussery's husband, who attended a screening of the film, said that Kallingal's portrayal was faithful and delivered "a flawless performance as Lini". Kallingal co-produced the film with Aashiq Abu under their production banner OPM Cinemas. Sowmya Rajendran described her performance as "expressive". In the 2021 film Santhoshathinte Onnam Rahasyam, directed by Don Palathara, Kallingal played an entertainment journalist opposite Jitin Puthenchery. Baradwaj Rangan described her performance as "terrific". The film won her Best Actress at the Diorama International Film Festival. In 2023 she appeared in Neelavelicham, a horror drama co-produced with Aashiq Abu. In 2025, Kallingal starred in Theatre, written and directed by Sajin Baabu, playing Meera, a woman who has lived an isolated life on a coastal Kerala island alongside her elderly mother. The film explores the conflict between traditional belief and modern science. The film had its world premiere at the Eurasian Bridge International Film Festival in Yalta on 9 October 2025, before its theatrical release on 16 October 2025. The role was physically demanding; director Sajin Baabu noted that Kallingal spent several hours atop a coconut tree for a single scene and completed multiple retakes despite sustaining bruises.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.